Nisa Investment Advisors, LLC Prothena Corp Public LTD CO Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,215 shares of PRTA stock, worth $18,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,215

Previous 1,041 16.71%

Holding current value

$18,492

Previous $21,000 4.76%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$16.73 - $24.79 $2,911 - $4,313	174 Added 16.71%	1,215 $20,000
Q2 2024 Jul 19, 2024	BUY	$19.54 - $26.15 $1,778 - $2,379	91 Added 9.58%	1,041 $21,000
Q1 2024 May 01, 2024	BUY	$24.75 - $40.66 $1,237 - $2,032	50 Added 5.56%	950 $23,000
Q4 2023 Jan 25, 2024	SELL	$32.31 - $52.32 $19,709 - $31,915	-610 Reduced 40.4%	900 $32,000
Q3 2023 Nov 02, 2023	BUY	$47.3 - $70.6 $946 - $1,412	20 Added 1.34%	1,510 $72,000
Q2 2023 Aug 11, 2023	BUY	$48.26 - $78.59 $25,095 - $40,866	520 Added 53.61%	1,490 $101,000
Q1 2023 May 02, 2023	BUY	$46.97 - $58.27 $20,901 - $25,930	445 Added 84.76%	970 $47,000
Q3 2022 Nov 07, 2022	BUY	$25.16 - $60.63 $629 - $1,515	25 Added 5.0%	525 $32,000
Q1 2022 Apr 29, 2022	SELL	$30.27 - $49.22 $90,174 - $146,626	-2,979 Reduced 85.63%	500 $18,000
Q4 2021 Feb 03, 2022	BUY	$42.11 - $73.26 $103,127 - $179,413	2,449 Added 237.77%	3,479 $119,000
Q2 2021 Aug 06, 2021	BUY	$21.63 - $57.65 $11,463 - $30,554	530 Added 106.0%	1,030 $53,000
Q1 2021 Apr 26, 2021	BUY	$11.0 - $28.24 $5,500 - $14,120	500 New	500 $13,000
Q4 2020 Jan 25, 2021	SELL	$10.12 - $13.94 $5,819 - $8,015	-575 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$6.89 - $10.45 $2,204 - $3,344	320 Added 125.49%	575 $5,000
Q2 2019 Jul 12, 2019	SELL	$8.85 - $12.49 $174,345 - $246,053	-19,700 Reduced 98.72%	255 $3,000
Q4 2018 Jan 17, 2019	BUY	$8.73 - $13.74 $171,981 - $270,678	19,700 Added 7725.49%	19,955 $206,000
Q3 2018 Oct 16, 2018	SELL	$12.7 - $15.79 $2,921 - $3,631	-230 Reduced 47.42%	255 $3,000
Q2 2018 Jul 19, 2018	BUY	$10.99 - $44.21 $3,406 - $13,705	310 Added 177.14%	485 $7,000
Q1 2018 Apr 10, 2018	BUY	$27.95 - $45.04 $4,891 - $7,882	175 New	175 $6,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Prothena Corp Public LTD CO Transaction History